Phase 1 multicenter, open-label study to establish the maximum tolerated dose (MTD) of two administration schedules of E7389 (eribulin) liposomal formulation in patients (pts) with solid tumors. A ...
NEW YORK, Sept. 3, 2025 /PRNewswire/ -- Today, EMED Technologies, a global leader in drug delivery and infusion therapy innovation, today announced the issuance of U.S. Patent No. 12,403,243 that ...
New York:, Jan. 30, 2023 (GLOBE NEWSWIRE) -- The global Intravenous Infusion Pumps Market was valued at US$ 5.2 Bn in 2021 and is expected to reach US$ 13.2 Bn by 2032, finds Persistence Market ...
Yttrium microspheres with cetuximab plus irinotecan for patients with advanced colorectal cancer metastases to liver. Background: Circadian clocks control drug metabolism and cell cycle over the 24 h ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results